Exane Derivatives’s Linde LIN Stock Holding History

Exane Derivatives’s Portfolio LIN Stock Details LIN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-26	Closed	-$3.26K	–	1061
2021 Q4	$3.26K	Sell	26 -846	-97%	-$274K	﹤0.01%	638
2021 Q3	$551K	Buy	872 +341	+64%	+$104K	0.13%	167
2021 Q2	$272K	Buy	531 +182	+52%	+$53.1K	0.06%	314
2021 Q1	$111K	Buy	349 +211	+153%	+$54.7K	0.03%	406
2020 Q4	$87K	Sell	138 -792	-85%	-$194K	0.03%	412
2020 Q3	$550K	Sell	930 -450	-33%	-$109K	0.16%	119
2020 Q2	$940K	Sell	1,380 -198	-13%	-$38.2K	0.25%	88
2020 Q1	$2.89M	Buy	1,578 +47	+3%	+$9.28K	0.81%	29
2019 Q4	$540K	Buy	1,531 +241	+19%	+$48.6K	0.1%	160
2019 Q3	$251K	Buy	1,290 +880	+215%	+$170K	0.05%	217
2019 Q2	$55.1K	Sell	410 -1,283	-76%	-$240K	0.01%	385
2019 Q1	$394K	Buy	1,693 +501	+42%	+$83.2K	0.08%	172
2018 Q4	$1.62M	Buy	+1,192	New	+$188K	0.29%	88

Other funds holding LIN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Exane Derivatives's LIN Position: Q2 2022 in Review

Exane Derivatives reduced its Linde (LIN) stake by 88% in Q2 2022, selling an estimated $573K and leaving 255 shares worth $72.6K. The position accounts for 0.04% of the portfolio, ranked #288.

Exane Derivatives first reported a position in LIN in Q4 2018 and has held it in 12 quarters since. The position peaked at $24.1M in Q4 2018. 1,419 funds tracked by Wall St. Rank hold LIN as of Q2 2022.

Exane Derivatives held 255 shares of Linde worth $72.6K as of Q2 2022.
Exane Derivatives sold 1,835 Linde shares in Q2 2022, an estimated $573K.
Linde made up 0.04% of Exane Derivatives's portfolio in Q2 2022, its #288 holding.
Exane Derivatives first reported a position in Linde in Q4 2018 and has held it in 12 quarters since.
Exane Derivatives's Linde position peaked at $24.1M in Q4 2018.
1,419 funds tracked by Wall St. Rank held Linde as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.